Published in PLoS Pathog on March 30, 2017
Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science (1998) 8.16
Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun (2001) 4.82
A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med (1996) 4.69
Urine is not sterile: use of enhanced urine culture techniques to detect resident bacterial flora in the adult female bladder. J Clin Microbiol (2013) 4.60
Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A (2006) 3.36
A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med (1993) 3.18
Clinical practice. Uncomplicated urinary tract infection. N Engl J Med (2012) 3.10
The female urinary microbiome: a comparison of women with and without urgency urinary incontinence. MBio (2014) 3.02
Risk factors for recurrent urinary tract infection in young women. J Infect Dis (2000) 2.48
Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun (2005) 2.10
The microbiome of the urinary tract--a role beyond infection. Nat Rev Urol (2015) 2.10
Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol (2015) 2.06
The association of urinary tract infection with sexual intercourse. J Infect Dis (1982) 2.05
Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection. Clin Infect Dis (2011) 1.94
Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol (2012) 1.94
Early severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infection. PLoS Pathog (2010) 1.88
Antibiotic prescribing for adults in ambulatory care in the USA, 2007-09. J Antimicrob Chemother (2013) 1.69
Urinary tract infection syndromes: occurrence, recurrence, bacteriology, risk factors, and disease burden. Infect Dis Clin North Am (2013) 1.67
Dysregulation of Escherichia coli α-hemolysin expression alters the course of acute and persistent urinary tract infection. Proc Natl Acad Sci U S A (2015) 1.62
Suprapubic aspiration of urine in pregnancy. Lancet (1968) 1.61
Risk factors associated with acute pyelonephritis in healthy women. Ann Intern Med (2005) 1.59
The mechanism of action of BCG therapy for bladder cancer--a current perspective. Nat Rev Urol (2014) 1.48
Urinary tract infections in women with bacterial vaginosis. Obstet Gynecol (2000) 1.34
New etiologic agent in nonspecific bacterial vaginitis. Science (1954) 1.30
Enterococcal biofilm formation and virulence in an optimized murine model of foreign body-associated urinary tract infections. Infect Immun (2010) 1.19
Ureaplasma urealyticum in the upper urinary tracts of renal allograft recipients. J Infect Dis (1981) 1.19
Urinary tract infections in pregnant women with bacterial vaginosis. Am J Obstet Gynecol (2002) 1.19
Association between bacterial vaginosis and acute cystitis in women using diaphragms. Arch Intern Med (1989) 1.15
Comparative genomic analyses of 17 clinical isolates of Gardnerella vaginalis provide evidence of multiple genetically isolated clades consistent with subspeciation into genovars. J Bacteriol (2012) 1.13
Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J Antimicrob Chemother (2005) 1.09
The female urinary microbiome in urgency urinary incontinence. Am J Obstet Gynecol (2015) 1.08
The Lung Microbiome: New Principles for Respiratory Bacteriology in Health and Disease. PLoS Pathog (2015) 1.07
Lactobacillus species as biomarkers and agents that can promote various aspects of vaginal health. Front Physiol (2015) 1.07
Gardnerella vaginalis comprises three distinct genotypes of which only two produce sialidase. Am J Obstet Gynecol (2011) 1.03
Degradation, foraging, and depletion of mucus sialoglycans by the vagina-adapted Actinobacterium Gardnerella vaginalis. J Biol Chem (2013) 0.99
Ureaplasma urealyticum in patients with acute symptoms of urinary tract infection. J Urol (1982) 0.98
Immune modulation by group B Streptococcus influences host susceptibility to urinary tract infection by uropathogenic Escherichia coli. Infect Immun (2012) 0.97
Characterization of a novel murine model of Staphylococcus saprophyticus urinary tract infection reveals roles for Ssp and SdrI in virulence. Infect Immun (2010) 0.96
Gardnerella vaginalis bacteremia in a previously healthy man: case report and characterization of the isolate. J Clin Microbiol (2007) 0.95
Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial. JAMA (1990) 0.94
Forced resurgence and targeting of intracellular uropathogenic Escherichia coli reservoirs. PLoS One (2014) 0.93
Clinical features of bacterial vaginosis in a murine model of vaginal infection with Gardnerella vaginalis. PLoS One (2013) 0.92
Increased urothelial cell apoptosis and chronic inflammation are associated with recurrent urinary tract infection in women. PLoS One (2013) 0.91
Genetic and biochemical diversity of Gardnerella vaginalis strains isolated from women with bacterial vaginosis. FEMS Immunol Med Microbiol (2012) 0.91
Anaerobic and other fastidious microorganisms in asymptomatic bacteriuria in pregnant women. J Infect Dis (1981) 0.89
Unconventional bacteria in urinary tract disease: Gardnerella vaginalis. Kidney Int (1983) 0.89
Comparison of mid catheter collection and suprapubic aspiration of urine for diagnosing bacteriuria due to fastidious micro-organisms. J Urol (1983) 0.86
Extra-vaginal infection caused by Gardnerella vaginalis. Epidemiol Infect (1987) 0.86
A novel mechanism of generating extracellular vesicles during apoptosis via a beads-on-a-string membrane structure. Nat Commun (2015) 0.85
β-Hemolysin/cytolysin of Group B Streptococcus enhances host inflammation but is dispensable for establishment of urinary tract infection. PLoS One (2013) 0.85
From physiology to pharmacy: developments in the pathogenesis and treatment of recurrent urinary tract infections. Curr Urol Rep (2013) 0.84
Impact of host age and parity on susceptibility to severe urinary tract infection in a murine model. PLoS One (2014) 0.84
Gardnerella vaginalis in the urinary tract: incidence and significance in a hospital population. Obstet Gynecol (1988) 0.83
Garnerella vaginalis bacteremia after vaginal myomectomy. Eur J Obstet Gynecol Reprod Biol (2003) 0.82
Gardnerella vaginalis septicaemia with pyelonephritis, infective endocarditis and septic emboli in the kidney and brain of an adult male. Int J STD AIDS (2010) 0.81
Diagnosing inflammation and infection in the urinary system via proteomics. J Transl Med (2015) 0.81
Association of urinary tract infection in women with bacterial vaginosis. J Glob Infect Dis (2009) 0.81
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease. J Immunol (2016) 0.80
Latent Mycobacterium tuberculosis Infection. N Engl J Med (2015) 0.80
Bacterial vaginosis: a synthesis of the literature on etiology, prevalence, risk factors, and relationship with chlamydia and gonorrhea infections. Mil Med Res (2016) 0.78
Repeated treatments with chitosan in combination with antibiotics completely eradicate uropathogenic Escherichia coli from infected mouse urinary bladders. J Infect Dis (2017) 0.76
Bacteremia of Gardnerella vaginalis after endometrial ablation. Arch Gynecol Obstet (2012) 0.76
Sex-induced cystitis--patient burden and other epidemiological features. Clin Exp Obstet Gynecol (2005) 0.76
Glycan cross-feeding supports mutualism between Fusobacterium and the vaginal microbiota. PLoS Biol (2020) 0.75
The sialate O-acetylesterase EstA from gut Bacteroidetes species enables sialidase-mediated cross-species foraging of 9-O-acetylated sialoglycans. J Biol Chem (2017) 0.75
Relationship between nugent score and vaginal epithelial exfoliation. PLoS One (2017) 0.75